Nasdaq · Medicinal Chemicals & Botanical Products
medical marijuana company based in Smiths Falls, Ontario
17 entities across 7 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-06-15 — see the exhibit.
| Entity | Jurisdiction | Note |
|---|---|---|
| Canada Inc. | Canada | |
| Apollo Applied Research Inc. | Canada | |
| Canopy Growth Australia PTY Ltd. | Australia | |
| Canopy Growth Germany GmbH | Germany | |
| Canopy Growth Holdings B.V. | Netherlands | |
| Canopy Growth LATAM Holdings Corporation | Canada | |
| Canopy Growth Polska Sp. Z. o. o. | Poland | |
| Canopy Growth USA, LLC | Delaware | |
| EB Transaction Corp. | Delaware | |
| EB Transaction Sub I LLC | Delaware | |
| IsoCanMed Inc. | Canada | |
| Montréal Cannabis Medical Inc. | Canada | |
| MTL Cannabis Corp. | Canada | |
| Storz & Bickel America, Inc. | California | |
| Storz & Bickel GmbH | Germany | |
| The Supreme Cannabis Company, Inc. | Canada | |
| Tweed Leasing Corp. | Canada |
Two standard screens, computed from the XBRL in FY2026 against FY2025. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2022 | — | — | — | — | — |
| FY2022 | — | — | — | — | — |
| FY2023 | $402.9M | −$3.3B | −$566.8M | -25.8% | 463,724,414 |
| FY2024 | $297.1M | −$657.3M | −$285.4M | 27.2% | 74,787,521 |
| FY2025 | $269.0M | −$598.1M | −$176.6M | 29.6% | 107,553,729 |
| FY2026 | $284.6M | −$262.9M | −$69.1M | 24.5% | 298,043,044 |
4 institutions tracked — 2 added, 2 reduced. Index money added 70 shares while active managers cut 1,474,106.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | Hedge fund | 1,786,444 | −1,450,884 | $1.7B |
| MORGAN STANLEY | Active fund | 1,946,294 | −23,346 | $1.8B |
| JPMORGAN CHASE & CO | Active fund | 521 | +124 | $518,000 |
| BlackRock Finance, Inc. | Index | 539 | +70 | $3,477 |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register. These filings span 2024-Q2–2026-Q2 rather than a single quarter, because filers report on their own schedules.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Canopy Growth Corp files under SIC 2833 — all 8 medicinal chemicals & botanical products companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
